PRA Genetic Subtypes in Welsh Springer Spaniels: Why the Specific Mutation Matters

Genetic testing labs often run multi-marker panels that screen for dozens of known PRA mutations at once, regardless of which breed a sample comes from, simply because it's efficient to test broadly rather than build a separate panel for every single breed. This means a Welsh Springer Spaniel's DNA panel can come back with results for mutations, including rcd3, that have their clearest documented history in an entirely different breed, in this case the Cardigan Welsh Corgi rather than the Welsh Springer Spaniel.

This matters because a result showing a Welsh Springer Spaniel as clear for rcd3 specifically doesn't tell an owner much, since this mutation isn't established as a meaningful risk in this breed's documented genetics in the first place. What actually matters for a Welsh Springer Spaniel is whether the panel includes markers for PRA forms with real documented relevance to the wider spaniel family this breed belongs to, since that's where an actual, plausible genetic risk would come from.

The practical takeaway is not to dismiss genetic testing, but to read results with real specificity: ask your vet or a veterinary genetics resource which specific markers on a given panel are actually established as relevant to Welsh Springer Spaniels, rather than treating every line on a multi-breed panel as equally meaningful. A clear result for an irrelevant mutation provides no real reassurance, and a positive result for one should be interpreted in that same breed-specific context.

A DNA panel is most useful when read with breed-specific context in mind, rather than treated as a single pass or fail verdict across every line it reports.